Skip to main content

Regulatory and Washington

  • Report: North Dakota pharmacy ownership bill defeated

    NORTH DAKOTA — A House bill that would have paved the path for chain and big-box pharmacy retailers to set up shop in North Dakota was rejected on Tuesday, according to a local news report.

    Under the current law, pharmacies must be majority-owned by a licensed pharmacist, but House Bill 1434 would have eliminated that portion of the law, the Bismarck Tribune reported. The bill was defeated 71-23.

    Those in favor of the bill said the state should open up the market to competition.

  • GPhA announces executive committee, board of directors

    ORLANDO, Fla. — The Generic Pharmaceutical Association has elected its 2011 executive committee and board of directors, the generic drug industry trade group announced. As part of a reorganization last year, the board has been reduced to 12 members.

    The GPhA said Watson Pharmaceuticals president and CEO Paul Bisaro had been reelected as chairman for a second, one-year term. Also elected were Mylan Pharmaceuticals president Tony Mauro, as vice chairman; and Momenta Pharmaceuticals president Craig Wheeler, as secretary treasurer.

  • Report: Arkansas considers switching PSE to Rx only

    LITTLE ROCK, Ark. — Arkansas on Friday became the fourth state this year to entertain making the popular decongestant pseudoephedrine available only by prescription.

  • Hi-Tech Pharmacal receives market exclusivity for generic Neurontin

    AMITYVILLE, N.Y. — Generic drug maker Hi-Tech Pharmacal has received Food and Drug Administration approval for its version of a drug used to treat neurological disorders, the company said Tuesday.

    Hi-Tech announced the approval of gabapentin oral solution in the 250 mg/5 mL strength, a generic version of Pfizer’s Neurontin oral solution.

    The drug is used to treat postherpetic neuralgia and epilepsy. Neurontin had sales of $15 million in 2010, according to IMS Health.

  • Perrigo files regulatory application for Taclonex generic

    ALLEGAN, Mich. — Generic drug maker Perrigo has filed for approval of a drug to treat psoriasis with the Food and Drug Administration.

    Perrigo announced Tuesday that it had filed an application with the FDA for calcipotriene and betamethasone dipropionate in the 0.005%/0.064% strength. The drug is a generic version of Leo Pharma’s Taclonex and is used to treat psoriasis vulgaris in adults.

  • First half of cold season ends with H1N1 hangover

    All the hype around H1N1 
that was so prevalent in 2009 is gone, leaving only the tough comparisons a year later. That makes the first half of the 
2010-2011 cough-cold season an H1N1 hangover with overall sales of $4.6 billion, representing a slight decline of 1.8%, for the 52 weeks ended Dec. 26, 2010, according to SymphonyIRI Group. What was missing in 2010 was the 2009 summer of sickness that reached a crescendo in September.

  • Time to ‘smah-ten up’

    “Smah-ten up, Ee-dah.” Loosely translated from deep “Mainer-ese,” that means, “smarten up, Eder.”


    It’s a voice from my childhood, an old coach and counselor from summer camp, Tobias Woodworth. I called him Toby. He called me “Ee-dah.”


    Stuck with me and all my other quasi-incorrigible New York City friends, Toby found himself saying, “smah-ten up!” an awful lot. It could mean anything from “you’ve got two strikes — protect the plate” to “put down that rock.”


  • NACDS, NCPA call pharmacy 'backbone of Medicaid's drug benefit'

    ALEXANDRIA, Va. — The National Association of Chain Drug Stores and the National Community Pharmacists Association on Friday sent a joint letter to every governor and state Medicaid director on the importance of pharmacies in Medicaid and the industry’s interest in working with state governments to cut costs.

X
This ad will auto-close in 10 seconds